Figure 3.
Impact of thyroid‐stimulating hormone (TSH) before liver transplantation on risk of death. The trend didn't change after adjusting for other risk factors, including age, gender, race/ethnicity, smoking, obesity, diabetes, hypertension, cirrhosis, neutrophil to lymphocyte ratio (NLR), alpha‐fetoprotein (AFP), model for end‐stage liver disease (MELD) score, tumor diameter, vascular invasion, Milan criteria. The adjusted hazard ratio for TSH >2.5 mIU/L is 1.05 (1.02, 1.09; P = 0.0012)